Patents for A61L 33 - Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment (5,725)
09/2002
09/26/2002DE10061573A1 Biokompatible Kolloide mit geringer Zelladhäsion und aktiver Stabilisierung von Blutproteinen Biocompatible colloids with low cell adhesion and active stabilization of blood proteins
09/25/2002EP1242130A1 Biocompatible coating
09/25/2002EP1242082A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders
09/24/2002US6454998 Polyethylenimine on a hemodialyser/hemofilter membrane of a copolymer of acrylonitrile and of sodium methallylsulphonate
09/19/2002WO2002072020A2 Novel anti-adhesive compounds and uses thereof
09/19/2002US20020133183 Coated medical devices
09/19/2002US20020133072 Graft polymerization of substrate surfaces
09/19/2002CA2441174A1 Novel anti-adhesive compounds and uses thereof
09/18/2002CN1369313A Inner salt of polysulfonic acid as biologic non-coagulating material and its preparing process
09/17/2002US6451044 Method and apparatus for heating inflammed tissue
09/12/2002WO2002070032A1 Plasma surface graft process for reducing thrombogenicity
09/12/2002CA2438624A1 Plasma surface graft process for reducing thrombogenicity
09/11/2002EP1237589A1 Coating medical device surfaces contacting gas-supersaturated fluids
09/06/2002WO2002067907A1 Compositions and methods for preventing platelet aggregation
09/04/2002EP0920342B1 Medical device for delivering a therapeutic substance
09/04/2002CN1367023A Preparation method of biodegradable medicine composite macromolecular scaffold material
09/04/2002CN1090202C Blood platelet metatolic inhibitor of supramolecular structure
09/04/2002CN1090201C Zeolite in packaging film
09/03/2002US6443942 Using polyoxyalkylene glycol hydrophilic surfactant
09/03/2002CA2247904C Zeolite in packaging film
09/03/2002CA2079778C Inhibitors of thrombin
08/2002
08/29/2002WO2002065947A2 Implants with fk506 for prophylaxis and treatment of restonoses
08/29/2002US20020117264 Method for treating a prosthesis having an apertured structure and associated devices
08/28/2002EP1233796A1 Biocompatible medical articles and process for their production
08/28/2002EP1233795A1 Electropolymerizable monomers and polymeric coatings on implantable devices
08/28/2002EP1233709A2 Prognostic testing of organs intended for transplantation
08/28/2002CN2507459Y Lung-shaped spring net/membrane
08/27/2002US6440565 Biocompatible metallic materials grafted with sulfonated poly(ethylene oxide) and preparation thereof
08/22/2002WO2002047738A3 Biocompatible colloids with reduced cell adhesion and active stabilisation of blood proteins
08/22/2002WO2002004008A3 Methods of therapy with thrombin derived peptides
08/22/2002US20020115836 Silyl heparin complex for use in attaching cells to prostheses, including vascular grafts and bone grafts
08/21/2002EP1231952A1 Method of covalent coupling
08/20/2002US6436135 Prosthetic vascular graft
08/15/2002WO2002062406A1 Dynamic implant coatings
08/15/2002WO2002036841A3 Heat treatment for cold worked nitinol to impart a shape setting capability without eventually developing stress-induced martensite
08/15/2002US20020111590 Medical devices, drug coatings and methods for maintaining the drug coatings thereon
08/15/2002US20020111393 Biocompatible medical devices with polyurethane surface
08/14/2002EP1229944A2 Medical article with a diamond-like carbon coating
08/13/2002US6432314 Anion exchange materials and processes
08/08/2002WO2002060509A1 Methods for surface modification
08/08/2002US20020107299 Non-oxidizing polymeric medical implant
08/08/2002CA2435962A1 Methods for surface modification
08/07/2002EP1228154A1 Zwitterionic polymer blend materials
08/01/2002WO2002058758A2 Antithrombogenic polymer coating
08/01/2002WO2002058753A2 Coating for implantable devices and a method of forming the same
08/01/2002WO2001037719A9 Prognostic testing of organs intended for transplantation
07/2002
07/31/2002EP1225946A1 Coating having biological activity and medical implant having surface carrying the same and method
07/25/2002WO2002056904A1 Biocatalytic and biomimetic generation of nitric oxide in situ at substrate/blood interfaces
07/25/2002WO2002035992A3 Tissue-engineered vascular structures
07/25/2002WO2002009647A3 Biological component comprising artificial membrane
07/25/2002CA2433803A1 Biocatalytic and biomimetic generation of nitric oxide in situ at substrate/blood interfaces
07/24/2002EP1223993A1 Biocompatible coated implant
07/24/2002EP1223951A1 Method of preventing adhesions with absorbable polyoxaesters
07/23/2002US6423232 Extra-corporal circulation, of a polyacrylonitrile bearind fixed negative charges based semi-permeable membrane
07/23/2002US6423024 Device for removing toxins from blood or plasma
07/18/2002WO2002055121A1 Drug delivery from stents
07/18/2002US20020095111 Healing transmyocardial implant
07/18/2002US20020094440 Implant with coating of copolymer of vinylidenefluoride (VDF) and/or tetrafluoroethylene (TFE) with another monomer in amounts effective to reduce thrombosis and/or restenosis when such stents are used in, e.g. angioplasty procedures
07/18/2002DE10139168A1 Insertion device for dialysis comprises an arterial and a venous system of halogen free materials having a specific bonding strength and blood compatibility value of less than five
07/17/2002EP1221997A1 System and device for preventing restenosis in body vessels
07/17/2002EP1221989A1 Intraluminal device, coating for such device, and method for preparing said device
07/16/2002US6419830 Surface modified polymer beads
07/11/2002WO2002038649A9 Two dimensional polyamides prepared from unsaturated carboxylic acids and amines
07/11/2002US20020091375 Stent lining
07/11/2002US20020091231 Device for removing toxins from blood or plasma
07/09/2002US6417161 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
07/09/2002US6417000 Suitable for the production of implants in which growth of endogenous or non-differentiated cells is desired such as artificial blood vessels; exemplified by: copolymer of acrylic acid, methyl methacrylate and sodium styrenesulfonate
07/04/2002WO2002026887A3 Crosslinked polyamide
07/04/2002US20020087184 Water-soluble coating for bioactive devices
07/04/2002US20020087123 Adhesion of heparin-containing coatings to blood-contacting surfaces of medical devices
07/04/2002US20020086989 Photoactivatable nucleic acid derivatives
07/02/2002US6413536 High viscosity liquid controlled delivery system and medical or surgical device
06/2002
06/26/2002CN1086592C Antibiosis anticoagulative silica gel catheter
06/25/2002US6409989 A free-flowing suspension of activated carbon particles ground and graded to <50 mu; antiagglomerants; grinding in a cylindrical rod mill in a chamber coated with a nonabrasive lining; accuracy
06/25/2002US6409716 Drug delivery
06/20/2002WO2002047738A2 Biocompatible colloids with reduced cell adhesion and active stabilisation of blood proteins
06/20/2002WO2002047582A2 Expandable stent with sliding and locking radial elements
06/20/2002US20020077544 Endoscopic targeting method and system
06/20/2002DE10035177C2 Verfahren zur plasmagestützten Behandlung der Innenfläche eines Hohlkörpers und Verwendung desselben Of the same method for the plasma assisted treatment of the inner surface of a hollow body and using
06/19/2002EP1214108A1 A porous prosthesis and a method of depositing substances into the pores
06/19/2002EP1214107A1 Graft polymerization of substrate surfaces
06/19/2002EP1214106A1 Cardiac valve and method for preparing a biological tissue
06/19/2002EP0808181B1 Process for the coating of objects with hyaluronic acid, derivatives thereof, and semisynthetic polymers
06/19/2002CN1086302C Separator thermosol dot type adhesive plaster and thermal melting device thereof
06/18/2002US6406792 Medical devices; crosslinked polysiloxane
06/18/2002US6406687 Polyoxyalkylene ether, sulfate, sulfonate and sulfamate as anticoagulants
06/18/2002US6406488 Healing transmyocardial implant
06/13/2002US20020071902 Applying a polymer in solvent mixture with finely divided bioactive species such as heparin, and curing, where the particle size of the bioactive species is selected to affect delivery kinetics
06/12/2002EP1212092A2 High viscosity liquid controlled delivery system and medical or surgical device
06/12/2002EP1060204B1 Sulphated hyaluronic acid and sulphated derivatives thereof covalently bound to polyurethanes, and the process for their preparation
06/12/2002EP0914348B1 Polymers for delivering nitric oxide in vivo
06/12/2002EP0820316B1 Coating for bio-material insertable into the bloodstream or tissue of the human body
06/11/2002US6403759 Polymers for delivering nitric oxide in vivo
06/11/2002US6403655 Method of preventing adhesions with absorbable polyoxaesters
06/06/2002US20020068950 Occlusion device with non-thrombogenic properties
06/06/2002US20020068804 Suitable for the production of implants in which growth of endogenous or non-differentiated cells is desired such as artificial blood vessels; exemplified by: copolymer of acrylic acid, methyl methacrylate and sodium styrenesulfonate
06/06/2002US20020068183 Antithrombogenic polymer coating
06/05/2002EP1211268A1 Random copolymer, process for the production thereof and medical material
06/05/2002EP1210954A1 New biocompatible polymer systems carrying triflusal or htb
06/05/2002CN1351892A In vivo self degraded epidural adhesion preventing and composite medicine slow-release biological film
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 58